数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

   BNGO
-- -- --

今开：-- 昨收：-- 最高：-- 最低：--
成交量：--万手 市盈率：-- 总市值($)：-- 换手率：--
加入自选股

首页概览 公司概况 财务分析 高管介绍 股本结构 公司新闻

股本结构

单位：万股
公告日期 2026-08-10 2026-08-10 2026-05-13 2026-05-13 2026-04-02 2026-03-23
证券总股本 1177.70 1177.73 1147.50 1127.65 1109.16 1074.02
普通股本 1177.70 1177.73 1147.50 1127.65 1109.16 1074.02
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2026-08-06 2026-06-30 2026-05-06 2026-03-31 2026-03-19 2025-12-31
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2026-08-10 1177.70 未披露 定期报告 2026-08-06
2026-08-10 1177.73 未披露
更多>>
From March 31,2026 to June 30,2026 Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes Issue common stock, net of issuance costs
2026-06-30
2026-05-13 1147.50 未披露 定期报告 2026-05-06
2026-05-13 1127.65 未披露
更多>>
From January 1,2026 to March 31,2026 Issue common stock and warrants, net of issuance costs
2026-03-31
2026-04-02 1109.16 未披露 定期报告 2026-03-19
2026-03-23 1074.02 未披露
更多>>
From December 31, 2024 to December 31, 2025 Issue common stock and warrants, net of issuance costs Issue stock for warrant exercises Issuance of common stock for convertible debentures payable Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
2025-12-31
2025-11-13 1017.60 未披露 定期报告 2025-11-05
2025-11-13 973.04 未披露
更多>>
From June 30,2025 to September 30,2025 Issue common stock, net of issuance costs Issue stock for warrant exercises
2025-09-30
2025-09-16 968.03 未披露
更多>>
Common Stock offered 4,925,000 shares by the company
2025-09-17
2025-09-11 475.53 未披露 定期报告 2025-09-09
2025-08-14 468.10 未披露 定期报告 2025-08-07
2025-08-14 390.94 未披露
更多>>
From March 31, 2025 to June 30, 2025 Issue common stock, net of issuance costs Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
2025-06-30
2025-05-14 336.40 未披露 定期报告 2025-05-07
2025-04-28 310.14 未披露 定期报告 2025-04-14
2025-05-14 310.14 未披露
更多>>
From January 1, 2025 to March 31, 2025 Issue common stock and warrants, net of issuance costs Issue stock for warrant exercises Issuance of common stock for convertible debentures payable
2025-03-31
2025-03-31 300.70 未披露 定期报告 2025-03-24
2025-02-21 273.28 未披露 定期报告 2025-02-17
2025-01-22 233.04 未披露
更多>>
a reverse stock split of common stock, at a ratio of 1-for-60
2025-01-27
2025-01-06 13982.42 未披露
更多>>
Common stock offered 22,900,000 shares by the company
2025-01-06
2025-01-06 11692.42 未披露 定期报告 2025-01-03
2024-11-14 10199.32 未披露 定期报告 2024-11-06
2024-10-31 9587.82 未披露
更多>>
Common Stock Offered 9,881,113 shares by the company
2024-10-31
2024-11-14 8846.80 未披露
更多>>
From June 30, 2024 to September 30, 2024 Issue common stock, net of issuance costs Issue stock for warrant exercises Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
2024-09-30
2024-07-31 8599.71 未披露 定期报告 2024-07-29
2024-07-08 8080.68 未披露
更多>>
Common stock offered 11,700,000 shares by the company
2024-07-08
2024-08-07 7077.60 未披露
更多>>
From March 31, 2024 to June 30, 2024 Issue stock for warrant exercises Issue stock for employee stock purchase plan Issue common stock, net of issuance costs
2024-06-30
2024-05-28 6910.68 未披露
更多>>
On May 24, 2024, Bionano Genomics, Inc. Sale by the Company in a private placement of 2,250,000 shares of the Company's common stock.
2024-05-24
2024-04-26 6685.68 未披露 定期报告 2024-04-15
2024-04-08 6123.07 未披露
更多>>
Common stock offered 6,536,682 shares by the company
2024-04-08
2024-05-08 5753.90 未披露
更多>>
From January 1, 2024 to March 31, 2024 Issue common stock, net of issuance costs
2024-03-31
2024-03-05 5469.40 未披露 定期报告 2024-02-29
2024-03-05 4575.20 未披露
更多>>
From December 31,2022 to December 31,2023 Stock option exercises Issue common stock, net of issuance costs Issue stock for employee stock purchase plan Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes Issuance of common stock for convertible notes payable
2023-12-31
2023-11-08 3884.03 未披露 定期报告 2023-11-06
2023-10-26 3772.29 未披露 定期报告 2023-10-23
2023-10-11 3534.84 未披露 定期报告 2023-10-11
2023-11-08 3534.90 未披露
更多>>
From June 30, 2023 to September 30, 2023 Stock option exercises Issue common stock, net of issuance costs Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
2023-09-30
2023-08-04 3067.90 未披露
更多>>
On August 4, 2023, Bionano Genomics, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the “Restated Certificate”), with the office of the Secretary of State of the State of Delaware to effect a reverse stock split at a ratio of 1:10 (the “Charter Amendment”).
2023-08-07
2023-05-09 30679.02 未披露 定期报告 2023-05-04
2023-04-28 30655.57 未披露 定期报告 2023-04-24
2023-05-09 30679.00 未披露
更多>>
From January 1, 2023 to March 31, 2023 Stock option exercises Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes Issue common stock, net of issuance costs
2023-03-31
2023-03-09 30623.90 未披露 定期报告 2023-03-06
2023-03-09 29718.30 未披露
更多>>
From December 31, 2021 to December 31, 2022 Stock option exercises Issue stock for employee stock purchase plan Issue common stock, net of issuance costs Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
2022-12-31
2022-11-03 29692.45 未披露 定期报告 2022-10-26
2022-11-03 29690.00 未披露
更多>>
From June 30, 2022 to September 30, 2022 Stock option exercises Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes Issue common stock, net of issuance costs
2022-09-30
2022-08-04 29013.99 未披露 定期报告 2022-07-27
2022-08-04 29006.10 未披露
更多>>
From March 31, 2022 to June 30, 2022 Stock option exercises Issue stock for employee stock purchase plan Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
2022-06-30
2022-05-05 28969.70 未披露 定期报告 2022-04-28
2022-04-27 28945.53 未披露 定期报告 2022-04-12
2022-05-05 28968.80 未披露
更多>>
From January 1, 2022 to March 31, 2022 Stock option exercises Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
2022-03-31
2022-03-01 28961.29 未披露 定期报告 2022-02-24
2022-03-01 28960.20 未披露
更多>>
From December 31, 2020 to December 31, 2021 Stock option exercises Issue common stock, net of issuance costs Issue stock for warrant exercises Issue stock for employee stock purchase plan Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes Issue stock for acquisition
2021-12-31
2021-11-04 28918.41 未披露 定期报告 2021-10-31
2021-11-04 28144.10 未披露
更多>>
From June 30, 2021 to September 30, 2021 Stock option exercises Issue common stock, net of issuance costs
2021-09-30
2021-08-04 27914.00 未披露 定期报告 2021-07-31
2021-08-04 27905.40 未披露
更多>>
From March 31, 2021 to June 30, 2021 Stock option exercises Issue stock for employee stock purchase plan Issue stock for warrant exercises
2021-06-30
2021-05-13 27884.96 未披露 定期报告 2021-05-07
2021-04-27 27879.45 未披露 定期报告 2021-04-01
2021-05-13 27879.40 未披露
更多>>
From January 1, 2021 To March 31, 2021 Stock option exercises Issue common stock, net of issuance costs Issue stock for warrant exercises
2021-03-31
2021-03-23 27866.15 未披露 定期报告 2021-03-12
2021-01-22 18168.09 未披露
更多>>
1.Common stock offered by the company 33,333,350 shares. 2.The number of shares of common stock to be outstanding immediately after this offering as shown above is based on 148,347,555 shares of common stock outstanding as of September 30, 2020.
2021-01-22
2021-01-20 23849.69 未披露 定期报告 2021-01-15
2021-01-12 17736.39 未披露
更多>>
1.Common stock offered by the company 29,016,393 shares. 2.The number of shares of common stock to be outstanding immediately after this offering as shown above is based on 148,347,555 shares of common stock outstanding as of September 30, 2020.
2021-01-12
2021-03-23 18995.29 未披露
更多>>
from December 31, 2019 to December 31, 2020 Issue stock, net of issuance costs Stock option exercises Issue stock for covenant waiver Issue stock for employee stock purchase plan Issue stock for acquisition Stock warrant exercises
2020-12-31
2020-11-13 15318.60 未披露 定期报告 2020-11-06
2021-01-07 14834.76 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issue stock for warrant exercises Issue stock for acquisition
2020-09-30
2020-08-13 13848.00 未披露 定期报告 2020-08-12
2020-08-03 13699.10 未披露 定期报告 2020-07-27
2020-08-13 9197.50 未披露
更多>>
From March 31, 2020 to June 30, 2020 Issue common stock, net of issuance costs Issue stock for employee stock purchase plan Issue stock for covenant waiver Issue stock for warrant exercises
2020-06-30
2020-06-18 8391.50 未披露 定期报告 2020-06-16
2020-05-19 6874.61 未披露 定期报告 2020-05-15
2020-05-19 6867.61 未披露 定期报告 2020-05-01
2020-04-06 5117.05 未披露
更多>>
On April 1, 2020, Bionano Genomics, Inc. (the “Company”) entered into an underwriting agreement with Oppenheimer & Co. Inc., as representative of the several underwriters named in Schedule I thereto, relating to the public offering, issuance and sale of 16,896,000 shares of its common stock and, to certain investors, pre-funded warrants to purchase 37,650,000 shares of its common stock, and accompanying common warrants to purchase up to an aggregate of 54,546,000 shares of its common stock. Each share of common stock and pre-funded warrant to purchase one share of common stock was sold together with a common warrant to purchase one share of common stock. The offering closed on April 6, 2020.
2020-04-06
2020-06-18 3775.20 未披露
更多>>
From December 31, 2019 to March 31, 2020 Issue stock for warrant exercises
2020-03-31
2020-03-10 3775.25 未披露 定期报告 2020-03-06
2020-03-10 3427.45 未披露
更多>>
From December 31, 2018 to December 31, 2019 Stock warrant exercises Issuance of common stock for Employee Stock Purchase Plan Issue stock for covenant waiver Stock option Exercises Issue common stock, net of issuance costs
2019-12-31
2019-11-07 2648.97 未披露 定期报告 2019-10-31
2019-10-23 2091.11 未披露 定期报告 2019-10-23
2019-08-08 1089.75 未披露
更多>>
From March 31, 2019 to June 30, 2019 Stock option exercises ESPP Purchases
2019-06-30
2019-05-09 1084.50 未披露
更多>>
from January 1, 2019 to March 31, 2019 Stock option exercises Issue common stock
2019-03-31
2019-04-24 1084.50 未披露 定期报告 2019-03-29
2019-03-29 1050.31 未披露 定期报告 2019-03-20
2019-03-14 1009.64 未披露 定期报告 2019-03-11
2019-03-14 1005.51 未披露
更多>>
from December 31, 2017 to December 31, 2018 Stock option exercises IPO Units Conversion of preferred stock upon IPO Conversion of convertible note upon IPO Purchase Plan
2018-12-31
2018-11-07 1003.27 未披露
更多>>
from December 31, 2017 to September 30, 2018 Stock option exercises IPO Units Conversion of preferred stock upon IPO Conversion of convertible note upon IPO
2018-09-30
2018-09-21 949.14 未披露 定期报告 2018-09-21
2018-08-17 7.80 12199.25
更多>>
from December 31, 2017 to June 30, 2018 Issuance of common stock (unaudited)
2018-06-30
2018-06-28 331.83 12199.25
更多>>
From December 31, 2017 To March 31, 2018 Issuance of common stock (unaudited)
2018-03-31
From March 31,2026 to June 30,2026 Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes Issue common stock, net of issuance costs
From January 1,2026 to March 31,2026 Issue common stock and warrants, net of issuance costs
From December 31, 2024 to December 31, 2025 Issue common stock and warrants, net of issuance costs Issue stock for warrant exercises Issuance of common stock for convertible debentures payable Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
From June 30,2025 to September 30,2025 Issue common stock, net of issuance costs Issue stock for warrant exercises
Common Stock offered 4,925,000 shares by the company
From March 31, 2025 to June 30, 2025 Issue common stock, net of issuance costs Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
From January 1, 2025 to March 31, 2025 Issue common stock and warrants, net of issuance costs Issue stock for warrant exercises Issuance of common stock for convertible debentures payable
a reverse stock split of common stock, at a ratio of 1-for-60
Common stock offered 22,900,000 shares by the company
Common Stock Offered 9,881,113 shares by the company
From June 30, 2024 to September 30, 2024 Issue common stock, net of issuance costs Issue stock for warrant exercises Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
Common stock offered 11,700,000 shares by the company
From March 31, 2024 to June 30, 2024 Issue stock for warrant exercises Issue stock for employee stock purchase plan Issue common stock, net of issuance costs
On May 24, 2024, Bionano Genomics, Inc. Sale by the Company in a private placement of 2,250,000 shares of the Company's common stock.
Common stock offered 6,536,682 shares by the company
From January 1, 2024 to March 31, 2024 Issue common stock, net of issuance costs
From December 31,2022 to December 31,2023 Stock option exercises Issue common stock, net of issuance costs Issue stock for employee stock purchase plan Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes Issuance of common stock for convertible notes payable
From June 30, 2023 to September 30, 2023 Stock option exercises Issue common stock, net of issuance costs Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
On August 4, 2023, Bionano Genomics, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the “Restated Certificate”), with the office of the Secretary of State of the State of Delaware to effect a reverse stock split at a ratio of 1:10 (the “Charter Amendment”).
From January 1, 2023 to March 31, 2023 Stock option exercises Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes Issue common stock, net of issuance costs
From December 31, 2021 to December 31, 2022 Stock option exercises Issue stock for employee stock purchase plan Issue common stock, net of issuance costs Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
From June 30, 2022 to September 30, 2022 Stock option exercises Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes Issue common stock, net of issuance costs
From March 31, 2022 to June 30, 2022 Stock option exercises Issue stock for employee stock purchase plan Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
From January 1, 2022 to March 31, 2022 Stock option exercises Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes
From December 31, 2020 to December 31, 2021 Stock option exercises Issue common stock, net of issuance costs Issue stock for warrant exercises Issue stock for employee stock purchase plan Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes Issue stock for acquisition
From June 30, 2021 to September 30, 2021 Stock option exercises Issue common stock, net of issuance costs
From March 31, 2021 to June 30, 2021 Stock option exercises Issue stock for employee stock purchase plan Issue stock for warrant exercises
From January 1, 2021 To March 31, 2021 Stock option exercises Issue common stock, net of issuance costs Issue stock for warrant exercises
1.Common stock offered by the company 33,333,350 shares. 2.The number of shares of common stock to be outstanding immediately after this offering as shown above is based on 148,347,555 shares of common stock outstanding as of September 30, 2020.
1.Common stock offered by the company 29,016,393 shares. 2.The number of shares of common stock to be outstanding immediately after this offering as shown above is based on 148,347,555 shares of common stock outstanding as of September 30, 2020.
from December 31, 2019 to December 31, 2020 Issue stock, net of issuance costs Stock option exercises Issue stock for covenant waiver Issue stock for employee stock purchase plan Issue stock for acquisition Stock warrant exercises
From June 30, 2020 to September 30, 2020 Issue stock for warrant exercises Issue stock for acquisition
From March 31, 2020 to June 30, 2020 Issue common stock, net of issuance costs Issue stock for employee stock purchase plan Issue stock for covenant waiver Issue stock for warrant exercises
On April 1, 2020, Bionano Genomics, Inc. (the “Company”) entered into an underwriting agreement with Oppenheimer & Co. Inc., as representative of the several underwriters named in Schedule I thereto, relating to the public offering, issuance and sale of 16,896,000 shares of its common stock and, to certain investors, pre-funded warrants to purchase 37,650,000 shares of its common stock, and accompanying common warrants to purchase up to an aggregate of 54,546,000 shares of its common stock. Each share of common stock and pre-funded warrant to purchase one share of common stock was sold together with a common warrant to purchase one share of common stock. The offering closed on April 6, 2020.
From December 31, 2019 to March 31, 2020 Issue stock for warrant exercises
From December 31, 2018 to December 31, 2019 Stock warrant exercises Issuance of common stock for Employee Stock Purchase Plan Issue stock for covenant waiver Stock option Exercises Issue common stock, net of issuance costs
From March 31, 2019 to June 30, 2019 Stock option exercises ESPP Purchases
from January 1, 2019 to March 31, 2019 Stock option exercises Issue common stock
from December 31, 2017 to December 31, 2018 Stock option exercises IPO Units Conversion of preferred stock upon IPO Conversion of convertible note upon IPO Purchase Plan
from December 31, 2017 to September 30, 2018 Stock option exercises IPO Units Conversion of preferred stock upon IPO Conversion of convertible note upon IPO
from December 31, 2017 to June 30, 2018 Issuance of common stock (unaudited)
From December 31, 2017 To March 31, 2018 Issuance of common stock (unaudited)